| Mepha Pharma AG - Mephameson 8 mg/2 ml, Injektionslösung |
| 31890 | | 03 | | Mephameson 8 mg/2 ml | | Injektionslösung | | H02AB02 | | Dexamethasone | | 15.11.1965 | | |
|
| Composition |
| dexamethasoni natrii phosphas 8.00 mg corresp. dexamethasonum 6 mg, dinatrii edetas, natrii chloridum, propylenglycolum 40.00 mg, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium max. 2.71 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Dexamethasone Sodium Phosphate | 8mg / 2ml correspond Dexamethasone 6mg / 2ml |
| | BAG: Active Agent | Dose |
|---|
| Dexamethasone Sodium Phosphate | 8 mg |
| | | | Inactive agents | Dose |
|---|
| Dinatrii Edetas | | | Sodium Chloride | | | Natrii Hydroxidum ad Ph | | | Propylenglycol | 40mg / 2ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 047 | 3 1 ampoule(s) à 2 ml | 10.05 | 27.35 | B | SL | Yes | | 063 | 50 1 ampoule(s) à 2 ml | 167.46 | 198.55 | B | SL | Yes |
|
